We are live on ! Find out more
CCCC icon

C4 Therapeutics
CCCC

114 hedge funds and large institutions have $353M invested in C4 Therapeutics in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 31 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

614% more call options, than puts

Call options by funds: $257K | Put options by funds: $36K

52% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 31

19% more capital invested

Capital invested by funds: $298M → $353M (+$55.1M)

1.5% more ownership

Funds ownership: 80.81% → 82.31% (+1.5%)

6% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 16

1% more funds holding

Funds holding: 113 → 114 (+1)

Holders
114
Holders Change
+1
Holders Change %
+0.88%
% of All Funds
1.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
47
Reduced
31
Closed
16
Calls
$257K
Puts
$36K
Net Calls
+$221K
Net Calls Change
-$2.03M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$12.9M
2
SCM
Soleus Capital Management
Connecticut
+$12M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$8.18M
4
Goldman Sachs
Goldman Sachs
New York
+$3M
5
WA
Wasatch Advisors
Utah
+$2.78M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$14.7M
2
ACH
ArrowMark Colorado Holdings
Colorado
-$7.79M
3
SFM
Sphera Funds Management
Israel
-$5.32M
4
Millennium Management
Millennium Management
New York
-$3.21M
5
RI
RTW Investments
New York
-$2.86M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northwestern Mutual Wealth Management
101
Northwestern Mutual Wealth Management
Wisconsin
$23K – – –
MLICM
102
Metropolitan Life Insurance Company (MetLife)
New York
$22.7K – – –
Simplex Trading
103
Simplex Trading
Illinois
$19K -$1.79K -172 -7%
PNC Financial Services Group
104
PNC Financial Services Group
Pennsylvania
$18K +$20.8K +2,000 New
EWM
105
Endurance Wealth Management
Rhode Island
$16K – – –
TIM
106
Tortoise Investment Management
New York
$13K – – –
Royal Bank of Canada
107
Royal Bank of Canada
Ontario, Canada
$9K +$2.88K +277 +36%
Federated Hermes
108
Federated Hermes
Pennsylvania
$9K +$10.3K +995 New
FHA
109
First Horizon Advisors
Tennessee
$8K +$1.41K +136 +15%
Allspring Global Investments
110
Allspring Global Investments
North Carolina
$6K -$14.5K -1,394 -65%
PSB
111
Piscataqua Savings Bank
New Hampshire
$5K – – –
CUAMC
112
China Universal Asset Management Company
China
$4K +$4.75K +458 New
LC
113
Lindbrook Capital
California
$3K +$3.16K +304 +981%
Daiwa Securities Group
114
Daiwa Securities Group
Japan
$1K – – –
SFM
115
Sphera Funds Management
Israel
– -$5.32M -705,736 Closed
Millennium Management
116
Millennium Management
New York
– -$3.21M -425,647 Closed
Marshall Wace
117
Marshall Wace
United Kingdom
– -$1.9M -252,326 Closed
PBA
118
Paradigm Biocapital Advisors
New York
– -$552K -73,149 Closed
TWM
119
TriaGen Wealth Management
California
– -$410K -54,424 Closed
E
120
Ergoteles
New York
– -$328K -43,500 Closed
ECM
121
ExodusPoint Capital Management
New York
– -$265K -35,197 Closed
PIMJS
122
PKO Investment Management Joint-Stock
Poland
– -$264K -35,000 Closed
DTL
123
Dynamic Technology Lab
Singapore
– -$248K -32,933 Closed
AI
124
Atom Investors
Texas
– -$207K -27,512 Closed
JF
125
Jump Financial
Illinois
– -$141K -18,721 Closed
2 3 4
5
6

CCCC Hedge Fund Activity: Q3 2022 in Review

114 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in C4 Therapeutics (CCCC) for Q3 2022, worth a combined $353M — up 19% from $298M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new CCCC positions and 16 closed out — a net gain of 1 holder — while 47 added to existing stakes and 31 trimmed.

The largest buyer was State Street, adding an estimated $12.9M. The largest seller was T. Rowe Price Associates, cutting an estimated $14.7M.

  • 114 institutional investors held C4 Therapeutics (CCCC) as of Q3 2022, up from 113 in Q2 2022.
  • Funds reported $353M of C4 Therapeutics stock for Q3 2022, up 19% quarter-over-quarter.
  • 17 funds opened new C4 Therapeutics positions in Q3 2022 and 16 closed out, a net change of +1 holder.
  • The largest C4 Therapeutics buyer in Q3 2022 was State Street, an estimated $12.9M added.
  • The largest C4 Therapeutics seller in Q3 2022 was T. Rowe Price Associates, an estimated $14.7M sold.

Based on aggregated 13F filings for Q3 2022.